- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Health Ministry Notifies Cosmetics Rules 2025, Empowers States To Suspend Licences

New Delhi: The Ministry of Health and Family Welfare has notified the Cosmetics (Amendment) Rules, 2025, making several key changes to the Cosmetics Rules, 2020, including clarification on expiry labelling, redefining regulatory terminology, updated recordkeeping norms, and introducing a new provision for licence cancellation or suspension.
The notification, published as G.S.R. 513(E) in the Gazette of India on 29th July 2025, states:
“Now, therefore, in exercise of the powers conferred by section 12 and section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government, after consultation with the Drugs Technical Advisory Board, hereby makes the following rules to amend the Cosmetics Rules, 2020.”
One of the significant changes is the insertion of a clear definition regarding expiry labels:
“For the purposes of this clause, the expression ‘use before’ means, use before the first day of a month mentioned on label and the expression ‘date of expiry’ mean the cosmetic expires on the last day of the month.”
The amendment also replaces the term “controlling officer” with “Controlling Authority” across multiple rules including Rules 6, 9, and 31(2). Further, Rule 7 has been substituted entirely to clarify that:
“The Government Analyst appointed under section 20 of the Act (23 of 1940) shall be the Government Analyst for the purposes of these rules.”
A major structural change has been introduced with the insertion of Rule 31A titled “Cancellation or suspension of licence.” It empowers the State Licensing Authority to cancel or suspend a licence in case of violations, stating:
“If a licensee fails to comply with any of the conditions of license or with any provision of the Act or the rules made thereunder, the State Licensing Authority may... cancel a licence issued under these rules or suspend it... wholly or in respect of some of the substances to which it relates.”
It also allows for an appeal:
“A licensee whose licence has been suspended or cancelled, may, within a period of ninety days... appeal to the State Government... and the order... shall be final.”
In another key compliance update, new clauses under Rule 26 mandate that:
“The licensee shall keep record of the details of each batch of cosmetic manufactured and of the raw materials used therein... and such records shall be retained for a period of three years or six months after expiry of the batch whichever is later.”
“The licensee shall test each batch or lot of the raw materials used... and also each batch of final product... and shall maintain records... retained for a period of three years or six months after expiry...”
However, these provisions exempt soap manufacturers:
“Provided that clauses (f) and (h) shall not apply to the manufacture of soap... approved by the Licensing Authority.”
Among other changes:
1. Rule 11 now designates the Central Drugs Laboratory to also serve as the Central Cosmetics Laboratory for analysis and appellate functions.
2. In cases of export, Rule 34(10) has been revised to clarify that:
“The label on package or container of cosmetic shall comply with the law of the country to which the cosmetic is to be exported... where a cosmetic is required by the consignee to be not labeled with the name and address of the manufacturer, the label... shall bear a code number as approved by the State Licensing Authority.”
Several terminologies across the rules have also been aligned—replacing “licence” with “approval,” and “licensed premises” with “approved premises,” in relevant provisions, including Rules 60, 61, and 62. Additionally, courier-based provisions in Rule 49 have been omitted.
The notification concludes:
“The principal rules were published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide notification number G.S.R.763 (E), dated the 15th December, 2020.”
To view the original Gazette, click on the link below:
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751